Pharmacologic control of thromboembolic complications of cardiac-valve replacement.
D000328:Adult; D000368:Aged; D001021:Aortic Valve / Q000601:surgery; D002986:Clinical Trials as Topic; D004176:Dipyridamole / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006350:Heart Valve Prosthesis; D006801:Humans; D008297:Male; D008875:Middle Aged; D008943:Mitral Valve / Q000601:surgery; D010919:Placebos; D011183:Postoperative Complications / Q000517:prevention & control*; D013923:Thromboembolism / Q000401:mortality / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D010919:Placebos; D014859:Warfarin; D004176:Dipyridamole